In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...